If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnteq Tech Regulatory News (NTQ)

  • This share is currently suspended. It was suspended at a price of 0.4999
  • There is currently no data for NTQ

Trading Update

10 Jan 2025 07:00

RNS Number : 8279S
Enteq Technologies PLC
10 January 2025
 

Enteq Technologies plc

("Enteq", the "Company" or the "Group")

Trading Update

 

Enteq Technologies plc (AIM:NTQ.L), the specialist energy services engineering and technology company, provides an update on trading and progress of the SABER Tool (Steer-At-Bit Enteq Rotary) technology.

 

Catoosa Test Facility, Oklahoma

· During December 2024, the Company undertook a demonstration test of its SABER tool at the industry test facility in Catoosa, Oklahoma. This drilling provided the opportunity to test operational functionality, and to implement engineering solutions identified during the recent customer trial process in Australia.

· The SABER tool again proved the principles of operation and steering by generating 'dog-leg', building and turning the angle during drilling, thereby achieving one of the key test objectives.

· Additionally, as a result of this testing the team have identified a number of engineering modifications and operational procedures to be implemented and tested in future drilling operations.

 

Commercialisation:

· Following the successful completion of passive test drilling operations with the customer in Australia in Q4 2024, the Company is now working (including incorporating the engineering modifications workstream referred to above) towards commencement of active test drilling operations. Based on the customer's current operational programme, this active test drilling is likely to commence in April 2025.

· Enteq continues to actively engage with potential customers, driven by the market and industry demand for a low cost to operate rotary steerable system.

 

Outlook:

· The Company is focused on preserving and managing cash. Due to the progress on commercialisation as described above, the timing of revenue previously expected to be earned is now more uncertain, and there will be costs associated with the engineering referred to above. Accordingly, the current cash runway, based on current cash resources, and before any potential cost savings, is now expected to be shorter than previously outlined at the time of the 2024 fundraise.

 

For further information, please contact:

Enteq Technologies plc +44 (0)20 8087 2202

www.enteq.com

Andrew Law, Chief Executive Officer

 

Cavendish Capital Markets Ltd (NOMAD and Broker) +44 (0)20 7220 0500

Ed Frisby, George Lawson (Corporate Finance)

Andrew Burdis, Jamie Anderson (Corporate Broking)

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF THE MARKET ABUSE REGULATION NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPKCBDDBKBNDK
Date   Source Headline
8th Jan 20243:59 pmRNSHolding(s) in Company
24th Nov 20237:00 amRNSPresenting at the MelloLondon Conference
15th Nov 20237:00 amRNSHalf-year Report
2nd Nov 202310:25 amRNSDirector/PDMR Shareholding
30th Oct 20234:08 pmRNSResult of General Meeting
23rd Oct 20237:00 amRNSAwards under the Enteq Performance Share Plan
18th Oct 202311:07 amRNSInvestor Presentation via Investor Meet Company
10th Oct 20237:00 amRNSAppointment of Non-Executive Director
6th Oct 20232:25 pmRNSHolding(s) in Company
4th Oct 20237:00 amRNSHolding(s) in Company
29th Sep 20237:00 amRNSAGM Statement and Board Update
22nd Sep 20233:29 pmRNSNotice of Final Results
19th Sep 20232:53 pmRNSHolding(s) in Company
6th Sep 20237:00 amRNSNotice of Annual General Meeting
9th Aug 20238:25 amRNSSABER System Field Trial Update
31st Jul 20239:30 amRNSNotice of Final Results
1st Jun 20232:30 pmRNSIssue of Shares and Director/PDMR Shareholdings
1st Jun 20237:00 amRNSAppointment of new CFO
12th Apr 20237:00 amRNSSale of XXT and Year-end Trading Update
29th Mar 20237:08 amRNSSale of Property
15th Feb 20237:00 amRNSSABER Tool Update
16th Nov 20221:25 pmRNSDirector/PDMR Shareholding
16th Nov 20227:00 amRNSInterim Results
21st Sep 20223:36 pmRNSResult of AGM
21st Sep 20229:05 amRNSSecond Price Monitoring Extn
21st Sep 20229:00 amRNSPrice Monitoring Extension
21st Sep 20227:00 amRNSAGM Trading Statement
2nd Aug 20225:43 pmRNSIssue of Shares and Director/PDMR Shareholding
8th Jul 20223:10 pmRNSDirector/PDMR Shareholding
6th Jul 20227:00 amRNSFinal Results and Investor Presentation
14th Apr 20221:00 pmRNSDirector/PDMR Shareholding
7th Apr 20227:00 amRNSYear-end Trading Update
8th Mar 20229:06 amRNSHolding(s) in Company
3rd Mar 20221:47 pmRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSBusiness Update and SABER Technology Progress
23rd Dec 202110:42 amRNSHolding(s) in Company
15th Dec 20213:39 pmRNSIssue of Shares and Director/PDMR Shareholding
18th Nov 20217:00 amRNSInterim Results
10th Nov 20217:00 amRNSExclusive Distributor Agreements Signed
8th Nov 20217:00 amRNSSABER Tool – Field Trial Update
28th Oct 20217:00 amRNSChange of Name
30th Sep 20214:05 pmRNSDirector/PDMR Shareholding
23rd Sep 20213:22 pmRNSResult of General Meeting and Change of Name
23rd Sep 20217:00 amRNSAGM Trading Statement
10th Aug 202110:30 amRNSDirector/PDMR Shareholding
26th Jul 20215:04 pmRNSDirector/PDMR Shareholding
14th Jul 20214:25 pmRNSIssue of shares and Director/PDMR Shareholding
7th Jul 20217:00 amRNSFinal Results & Investor Presentation
30th Apr 20217:00 amRNSContract award
19th Apr 20217:00 amRNSChange of Nominated Adviser and Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.